Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction

被引:65
作者
Bunte, M. C. [2 ]
Patnaik, M. M. [2 ]
Pritzker, M. R. [2 ,3 ]
Burns, L. J. [1 ,2 ]
机构
[1] Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Div Cardiol, Minneapolis, MN 55455 USA
关键词
pulmonary veno-occlusive disease; endothelial dysfunction; hematopoietic stem cell transplant; defibrotide;
D O I
10.1038/sj.bmt.1705990
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Veno-occlusive disease is among the most serious complications following hematopoietic stem cell transplantation. While hepatic veno-occlusive disease occurs more commonly, the pulmonary variant remains quite rare and often goes unrecognized antemortem. Endothelial damage may represent the pathophysiologic foundation of these clinical syndromes. Recent advances in the treatment of hepatic veno-occlusive disease may have application to its pulmonary counterpart.
引用
收藏
页码:677 / 686
页数:10
相关论文
共 83 条
[51]  
Or R, 1997, RESPIRATION, V64, P170
[52]   PULMONARY VENOOCCLUSIVE DISEASE AND ITS RESPONSE TO VASODILATOR AGENTS [J].
PALEVSKY, HI ;
PIETRA, GG ;
FISHMAN, AP .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (02) :426-429
[53]   Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease [J].
Palmer, SM ;
Robinson, LJ ;
Wang, AD ;
Gossage, JR ;
Bashore, T ;
Tapson, SF .
CHEST, 1998, 113 (01) :237-240
[54]  
RAMBIHAR VS, 1979, CAN MED ASSOC J, V15, P19
[55]   Expression of xenobiotic-metabolizing CYPs in human pulmonary tissue [J].
Raunio, H ;
Hakkola, J ;
Hukkanen, J ;
Lassila, A ;
Paivarinta, K ;
Pelkonen, O ;
Anttila, S ;
Piipari, R ;
Boobis, A ;
Edwards, RJ .
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 1999, 51 (4-5) :412-417
[56]  
Richardson P, 1996, BLOOD, V88, P1821
[57]  
Richardson PG, 1997, BLOOD, V90, P1107
[58]  
Richardson PG, 1998, BLOOD, V92, P737
[59]   N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation [J].
Ringdén, O ;
Remberger, M ;
Lehmann, S ;
Hentschke, P ;
Mattsson, J ;
Klaesson, S ;
Aschan, J .
BONE MARROW TRANSPLANTATION, 2000, 25 (09) :993-996
[60]  
Roychowdhury M, 2005, ARCH PATHOL LAB MED, V129, P366